鼻内镜下保留鼻黏骨膜瓣泪囊鼻腔造口术临床疗效分析

目的探讨鼻内镜下保留鼻黏膜瓣泪囊鼻腔造口术治疗慢性泪囊炎的临床疗效及安全性。方法耳鼻咽喉我科近年来开展鼻内镜下保留鼻黏膜瓣泪囊鼻腔造口术治疗慢性泪囊炎患者26例(28眼)的临床资料进行回顾性分析,观察临床疗效及并发症发生情况。结果 26例中治愈21例(23眼),占82.1%,好转3例(3眼),占10.7%,无效2例(2眼),占7.1%,总有效率为92.9%。2例无效者经扩大骨窗清除肉芽后症状消失。随访6个月以上,该组患者均无手术并发症,效果满意。结论鼻内镜下保留鼻腔黏膜瓣泪囊鼻腔造口术可最大程度地避免和减少骨质和瘢痕增生,疗效显著,安全性好,不影响美容、微创,是当前治疗慢性泪囊炎更为理想的方法。

Objective To analyze the clinical feasibility and efficacy of the preserved nasal mucosal flap intranasal endoscopic dacryocystorhinostomy in treating chronic dacryocystitis. Methods The preserved nasal mucosal flap intranasal endoscopic dacryocystorhinostomy has been carried out in 26 cases（28 eyes） patients with chronic dacryocystitis since three years, The patient＇s clinical data were retrospectively analyzed to observe the clinical efficacy and complications occurrence. Results 21cases （23 eyes, 82.1%） were cured, 3 sides（3eyes, 10.7%） were inproved,2 sides（2eyes 7.1%） were ineffective, the total effective rate was 92.9%.After the bone window of ineffectivel case was expanded and granulation was removed, clinical symptoms disappeared.lacrimal duct become unobstructed. The follow up more than six mouths showed that no complications took place and the clinical effect was satisfactory.Conclusion The preserved nasal mucosal flap intranasal endoscopic dacryocystorhinostomy would avoid scar formation and hyperostosis and is effective and safe, It is a more ideal method, because it is minimal invasive technique and does not affect the face cosmetology.